GSK PLC (GSK)
36.97
+0.09
(+0.24%)
USD |
NYSE |
Nov 04, 16:00
36.98
+0.01
(+0.03%)
After-Hours: 20:00
GSK Price: 36.97 for Nov. 4, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 04, 2024 | 37.03 | 37.26 | 36.94 | 36.97 | 3.993M |
| Nov 01, 2024 | 37.59 | 37.60 | 36.85 | 36.88 | 6.877M |
| Oct 31, 2024 | 36.27 | 37.01 | 36.07 | 36.76 | 12.12M |
| Oct 30, 2024 | 36.50 | 37.23 | 36.28 | 37.01 | 13.42M |
| Oct 29, 2024 | 37.94 | 38.26 | 37.88 | 38.17 | 6.141M |
| Oct 28, 2024 | 37.70 | 38.08 | 37.67 | 37.88 | 4.112M |
| Oct 25, 2024 | 37.95 | 38.00 | 37.43 | 37.52 | 3.375M |
| Oct 24, 2024 | 38.03 | 38.19 | 37.66 | 37.74 | 4.666M |
| Oct 23, 2024 | 37.74 | 37.99 | 37.65 | 37.98 | 4.866M |
| Oct 22, 2024 | 37.72 | 38.04 | 37.72 | 38.00 | 3.890M |
| Oct 21, 2024 | 38.49 | 38.51 | 38.08 | 38.16 | 2.873M |
| Oct 18, 2024 | 38.80 | 38.84 | 38.38 | 38.55 | 3.727M |
| Oct 17, 2024 | 39.21 | 39.24 | 38.92 | 38.96 | 4.991M |
| Oct 16, 2024 | 38.90 | 39.28 | 38.90 | 39.21 | 4.953M |
| Oct 15, 2024 | 38.93 | 39.40 | 38.82 | 38.96 | 4.291M |
| Oct 14, 2024 | 39.17 | 39.23 | 38.84 | 39.13 | 4.799M |
| Oct 11, 2024 | 39.02 | 39.15 | 38.63 | 38.83 | 7.244M |
| Oct 10, 2024 | 40.29 | 40.37 | 39.06 | 39.21 | 7.775M |
| Oct 09, 2024 | 37.88 | 41.80 | 37.80 | 40.24 | 19.97M |
| Oct 08, 2024 | 38.31 | 38.38 | 37.94 | 38.02 | 4.626M |
| Oct 07, 2024 | 39.04 | 39.12 | 38.61 | 38.63 | 3.853M |
| Oct 04, 2024 | 38.07 | 38.84 | 37.93 | 38.82 | 6.582M |
| Oct 03, 2024 | 38.60 | 38.65 | 38.16 | 38.37 | 5.361M |
| Oct 02, 2024 | 40.10 | 40.11 | 39.37 | 39.45 | 5.384M |
| Oct 01, 2024 | 40.47 | 40.57 | 40.28 | 40.30 | 3.121M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
28.66
Minimum
Sep 27 2022
48.75
Maximum
Jan 17 2020
39.57
Average
39.64
Median
Price Benchmarks
| AstraZeneca PLC | 71.42 |
| Pfizer Inc | 27.76 |
| Adaptimmune Therapeutics PLC | 0.8148 |
| TC BioPharm (Holdings) PLC | 1.39 |
| Moderna Inc | 53.54 |
Price Related Metrics
| PE Ratio | 24.03 |
| PS Ratio | 1.920 |
| Price to Book Value | 4.024 |
| Price to Free Cash Flow | 12.59 |
| Earnings Yield | 4.16% |
| Market Cap | 75.43B |
| Operating PE Ratio | 13.45 |
| Normalized PE Ratio | 20.51 |